Results 101 to 110 of about 780 (156)

Severe novel coronavirus infection in late pregnancy: a case report [PDF]

open access: yes
This study reported the diagnosis, treatment and perinatal outcome of a novel coronavirus infection patient at 29+6 weeks pregnancy. The patient case came to the hospital with persistent fever and cough for 6 days.
Liu, Jingjing   +3 more
core   +2 more sources

A Retrospective Analysis of Azvudine in Patients with COVID-19 and Pre-existing Cancer

open access: yesJournal of Cancer
Objectives: Azvudine has been recommended as a potential treatment for the recently discovered Coronavirus disease (COVID-19) in 2019. However, the effectiveness of Azvudine in individuals who have both COVID-19 and pre-existing cancer remains uncertain.
Li, Fangyu   +5 more
openaire   +2 more sources

Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study

open access: yesScientific Reports
This study aimed to explore the effectiveness and safety of azvudine, nirmatrelvir/ritonavir, and molnupiravir in adult patients with mild-to-moderate COVID-19.
Mei-Ping Chen   +4 more
doaj   +1 more source

Antiviral effectiveness and survival correlation of azvudine and nirmatrelvir/ritonavir in elderly severe patients with COVID-19: a retrospective real-world studyResearch in context

open access: yesEClinicalMedicine
Summary: Background: Azvudine and nirmatrelvir/ritonavir are approved to treat mild-to-moderate coronavirus disease 2019 (COVID-19) in adults with a high risk for progression to severe infection.
Shuxia Wang   +46 more
doaj   +1 more source

Coronavirus Disease 2019 Case Series in China: Sequelae and Effectiveness of Vaccination and Antiviral Drugs [PDF]

open access: yes
Min Ren Department of Emergency, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Min Ren, Department of Emergency, Emergency and Critical Care Medical ...
Ren M
core   +1 more source

Azvudine Suppresses Epithelial–Mesenchymal Transition in Hepatocellular Carcinoma by Targeting the Notch–HEY Signalling Pathway

open access: yesInternational Journal of Molecular Sciences
Azvudine (FNC) is a novel cytidine analogue that is widely used in the treatment of infectious diseases such as AIDS and COVID-19. Previous studies have demonstrated its anticancer activity in various cancer cell lines, including non-Hodgkin’s lymphomas and lung adenocarcinoma cell lines.
Yao Meng   +10 more
openaire   +1 more source

Comparison of the therapeutic effect of Paxlovid and Azvudine in the treatment of COVID-19: A retrospective study

open access: yesJournal of Infection and Public Health
Background: COVID-19 pneumonia has spread across China and globally since late 2019, becoming a pandemic. Its extremely contagious nature as well as high morbidity and mortality rates have attracted widespread attention globally.
Wei Yang   +6 more
doaj   +1 more source

Masthead: (View 2/2025)

open access: yes
VIEW, Volume 6, Issue 2, April 2025.
wiley   +1 more source

Antiviral effect of azvudine and nirmatrelvir-ritonavir among hospitalized patients with COVID-19

open access: yesJournal of Infection, 2023
Yuan Gao   +9 more
openaire   +2 more sources

Investigation of epidemiological and clinical characteristics of people infected with SARS-CoV-2 during the second pandemic of COVID-19 in Chengdu, China [PDF]

open access: yes
ObjectiveThis study investigated the epidemiological and clinical characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infected patients during the second pandemic of COVID-19 (coronavirus disease of 2019) in Chengdu, China ...
Cheng Li   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy